Application of vision transformers to protein-ligand affinity prediction.

18 April 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Predicting protein-ligand binding affinity from three-dimensional (3D) structural data is a central task in structure-based drug discovery, yet it remains challenging due to limited data availability, structural complexity, and the sparse nature of 3D molecular representations. In this study, we investigate the application of Vision Transformers (ViTs) to the problem of affinity prediction. We evaluate our approach across two benchmark datasets, demonstrating competitive performance, and in some cases surpassing, state-of-the-art models. We study hyperparameter influence and analyze the model behavior using explainable AI (XAI) techniques. We reveal that spatially proximal patches with similar attention scores cluster around biologically relevant regions, confirming the model’s ability to capture key interaction features. Furthermore, we show that data augmentation strategies can yield performance improvements, underscoring the potential for further enhancement. Despite challenges related to data sparsity and conformational variability, Vision Transformers show strong performance and robustness in structure-based affinity prediction tasks. Our findings highlight their effectiveness in learning spatial patterns and suggest broader applicability to related tasks, such as protein–protein or protein–nucleic acid interaction modeling.

Keywords

Vision transformers
ligand binding
affinity prediction
machine learning
eXplainable AI
molecular dynamics

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.